Refine by
Cell Line Development Articles & Analysis
15 news found
Patricia Industries’ subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, today announced the execution of a definitive agreement to acquire Nova Biomedical, a manufacturer of innovative analytical instruments and consumables that are vital in guiding the treatment of patients and the development of biotechnology ...
Attendees will learn how to integrate automated glycan profiling into cell line development (CLD) labs. Early glycan screening is a cornerstone for ensuring long-term biologic quality and accelerating decision-making in cell line development (CLD). ...
Introduction We recently sat down with one of our valued customers, Dr Alexis Rossignol (Clean Cells), to discuss his experience with VIPS PRO, our cutting-edge technology designed to streamline and enhance the early stages of cell line development. This interview provides insight into Clean ...
ExcellGene SA, a leading Swiss biotech service provider specializing in mammalian cell line development for more than two decades, proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization (CDMO) based in the USA. As CHO (Chinese Hamster Ovary) and HEK ...
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug development processes, driving down development costs and enabling an ...
ByCELLINK
The companies will join forces to provide ‘end-to-end’ Contract Development Manufacturing Organization (CDMO) services to their clients, from pharmaceutical cell line development to large-scale contract manufacturing. EXCELLGENE will provide clients with services such as cell line ...
Known for its competence, responsibility, and innovative capability in chemical supply, Alfa Chemistry recently unveiled its new role as a CDMO service provider for pharmaceutical companies worldwide. Contract Development and Manufacturing Organization, abbreviated as CDMO, is a preferential way for a majority of pharmaceutical companies to outsource ongoing drug ...
MatTek Life Sciences will distribute Cell4Pharma’s ciPTEC renal cells and utilize the technology in the development of a new in vitro kidney model. ...
From this site, ARTES today operates worldwide from 850 sqm S1 facilities with a team of 24 employees. Our main business has developed in 20 years very continuously. From offering “only” cell line development in our “working horse” Hansenula polymorpha, we nowadays offer the whole ...
Womack will serve as the Chief Executive Officer of two of its affiliate companies: KBI Biopharma, a leading global CDMO specializing in drug development and biologics manufacturing, and Selexis SA, an industry-leading cell line development provider. ...
With this recognition BICO has entered the Top 100 companies for In House design and this is a great testament to the emphasis that we as a group are putting on design. We are focused on developing customer centric solutions that will support reducing the world’s organ shortages and speed up drug ...
With locations in the US and Europe, today MatTek's offerings include skin, eye, oral, respiratory, vaginal, and intestinal tissue models including disease modeling, validated, and custom testing services, multiple donor primary cells, culture media, and highly optical cultureware. About BICO Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the ...
Orbit will also utilise other capabilities within WuXi AppTec, in particular their expertise in cell line and assay development and biophysical analysis. Incorporating these capabilities into the Orbit platform will enable functional assays to be developed against a wider range of targets, facilitating direct functional screens ...
Merck is known to evaluate in various pipelines and development knowhow of high expression CHO cell line of GI Innovation. ...
BIO DIGITAL 2021 – New and emerging biopharma companies working on early development can now leverage a better lab to clinic drug development solution designed to accelerate the journey from DNA to drug product. ...